Literature DB >> 7525477

Roles for protein kinases in the induction of nitric oxide synthase in astrocytes.

M L Simmons1, S Murphy.   

Abstract

Lipopolysaccharide (LPS) or a combination of interferon (IFN)-gamma and interleukin (IL)-1 beta can induce a calcium-independent nitric oxide synthase (iNOS) in astrocyte cultures (Simmons and Murphy: J Neurochem 59:897, 1992; Eur J Neurosci 5:825, 1993; Galea et al: Proc Natl Acad Sci USA 89:10945, 1992). This induction can be measured by assaying cyclic GMP levels in the cultures, which correlates with, but is more sensitive than, measurement of nitrite accumulation. To study potential second-messenger systems involved in the induction of iNOS, phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, and various protein kinase inhibitors were employed. PMA induced a time-, dose-, and L-arginine-dependent increase in cyclic GMP, which could be inhibited by dexamethasone or actinomycin D. This induction could be dramatically increased by concurrent treatment with IFN-gamma. The presence of iNOS mRNA could be demonstrated by hybridization with a specific cDNA probe. H7 (a non-specific serine/threonine kinase inhibitor) but not H89 (a more specific PKA inhibitor) prevented induction by all agents. However, downregulation of PKC or pretreatment with the PKC inhibitor calphostin C did not prevent the induction by LPS or cytokines, suggesting that PKC is not necessary for iNOS induction by these mediators. Additionally, genistein (a nonspecific tyrosine kinase inhibitor) could prevent induction by all agents, but the more specific inhibitor, tyrphostin, attenuated only NOS induction by LPS. These results suggest that activation of PKC can lead to, but is not necessary for, the induction of NOS in astrocytes and that there is a potential role for tyrosine kinases in NOS induction by LPS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525477     DOI: 10.1002/glia.440110303

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  7 in total

1.  Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression.

Authors:  V Trajković; V Badovinac; D Popadić; O Hadzić; M M Stojković
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

Review 2.  Regulation of inducible nitric oxide synthase gene in glial cells.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

3.  Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis.

Authors:  D C Hooper; O Bagasra; J C Marini; A Zborek; S T Ohnishi; R Kean; J M Champion; A B Sarker; L Bobroski; J L Farber; T Akaike; H Maeda; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.

Authors:  O Bagasra; F H Michaels; Y M Zheng; L E Bobroski; S V Spitsin; Z F Fu; R Tawadros; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.

Authors:  Lucia Lisi; Pierluigi Navarra; Douglas L Feinstein; Cinzia Dello Russo
Journal:  J Neuroinflammation       Date:  2011-01-05       Impact factor: 8.322

Review 6.  Production, regulation and role of nitric oxide in glial cells.

Authors:  V A Vincent; F J Tilders; A M Van Dam
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

7.  Alzheimer's amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes.

Authors:  Norman J Haughey; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.